methylenedioxyethamphetamine
Also known as N-ethyl-α-methyl-1,3-benzodioxole-5-ethanamine, 1,3-benzodioxole-5-ethanamine, N-ethyl-α-methyl-, MDEA, (+/-)-MDE, 3,4-methylenedioxy-N-ethylamphetamine, MDE, n-ethyl MDA, 3,4-Methylenedioxy-N-ethylamphetamine
'3,4-Methylenedioxy-N-ethylamphetamine (MDEA; also called MDE and colloquially, Eve') is an empathogenic psychoactive drug. MDEA is a substituted amphetamine and a substituted methylenedioxyphenethylamine. MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent and reuptake inhibitor.
Key facts
- Drug.legal_CA
- Schedule I
- Drug.drug_name
- MDEA
- Drug.image
- MDEA structure.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 235px
- Drug.image2
- MDEA molecule ball.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 250px
- Drug.routes_of_administration
- Oral, insufflation, injection, rectal
- Drug.class
- Serotonin releasing agent; Entactogen
- Drug.ATC_prefix
- None
- Drug.legal_AU
- S9
- Drug.legal_BR
Article
15 sectionsContents
- Uses
- Medical
- Recreational
- Adverse effects
- Overdose
- Interactions
- Chemistry
- Synthesis
- History
- Society and culture
- Legal status
- United States
- See also
- References
- External links
'3,4-Methylenedioxy-N-ethylamphetamine (MDEA; also called MDE and colloquially, Eve') is an empathogenic psychoactive drug. MDEA is a substituted amphetamine and a substituted methylenedioxyphenethylamine. MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent and reuptake inhibitor.
Possession of MDEA is illegal in most countries. Some limited exceptions exist for scientific and medical research.
Connections
Categories
Chemical pages without DrugBank identifierDesigner drugsDrugs not assigned an ATC codeECHA InfoCard ID from WikidataEntactogensEuphoriantsInfobox drug articles with non-default infobox titleMethylenedioxyamphetaminesPartial monoamine releasing agentsPiHKALSerotonin-norepinephrine-dopamine releasing agentsSerotonin receptor agonists